Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for June 10th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, June 10th:

China Yuchai International Limited (CYD - Free Report) : This diesel and natural gas engines manufacturer has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 5.2% over the last 60 days.

China Yuchai International has a price-to-earnings ratio (P/E) of 5.49, compared with 7.00 for the industry. The company possesses a Value Score of A.

Meritor, Inc. : This manufacturer of integrated systems, modules and components to original equipment manufacturers has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 5.4% over the last 60 days.

Meritor has a price-to-earnings ratio (P/E) of 6.19, compared with 7.00 for the industry. The company possesses a Value Score of A.

Meritor, Inc. PE Ratio (TTM)

Meritor, Inc. PE Ratio (TTM)

Meritor, Inc. pe-ratio-ttm | Meritor, Inc. Quote

L Brands, Inc. : This specialty retailer has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 2.1% over the last 60 days.

L Brands has a price-to-earnings ratio (P/E) of 9.44, compared with 11.50 for the industry. The company possesses a Value Score of B.

L Brands, Inc. PE Ratio (TTM)

L Brands, Inc. PE Ratio (TTM)

L Brands, Inc. pe-ratio-ttm | L Brands, Inc. Quote

China Distance Education Holdings Limited : This online and offline education services provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 1.7% over the last 60 days.

China Distance Education has a price-to-earnings ratio (P/E) of 9.03 compared with 17.40 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


China Yuchai International Limited (CYD) - free report >>

Published in